Enterococcus Polypeptides Induce Opsonic Antibodies
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bacterial infections caused by Enterococci, particularly in immunocompromised patients and hospital settings, are limited due to antibiotic resistance and the lack of effective vaccine targets that induce protective antibodies.
Innovation Solution
Development of a medicament containing specific polypeptides (SEQ ID NO: 1 to 9) that induce opsonic antibodies, used to create a vaccine targeting Enterococcus infections by stimulating the immune response to prevent or treat bacterial infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat Enterococcus infections, then bacterial growth is inhibited, but antibiotic resistance develops and spreads rapidly
Solution Approach 1:
Instead of using antibiotics to kill bacteria directly, the invention inverts the approach by using the bacteria's own cell wall components (polypeptides) as antigens to stimulate the immune system to produce antibodies that will neutralize the bacteria. This avoids the harmful selection pressure that leads to antibiotic resistance.
Solution Approach 2:
The invention introduces an intermediary mechanism - the immune system - between the treatment and the pathogen. Rather than direct chemical warfare with antibiotics, the polypeptide antigens mediate an immune response that produces antibodies as intermediaries to eliminate the bacteria, bypassing the resistance problem.
2Adaptability or versatility
If new antibiotics are introduced to treat resistant strains, then treatment options are expanded, but resistance against these new drugs develops and spreads rapidly
Solution Approach 1:
The invention applies preliminary action by developing a vaccine that primes the immune system before infection occurs. The polypeptide antigens are introduced in advance to stimulate memory B-cells and antibody production, so when infection occurs, the immune system is already prepared to respond effectively, preventing the need for new antibiotics and the subsequent development of resistance.
3Reliability
If polypeptides are used to induce opsonic antibodies, then protective immune response is enhanced, but vaccine development complexity increases
Solution Approach 1:
The invention extracts specific protective polypeptides from the complex Enterococcus cell wall structure and uses only these essential antigenic components for vaccine formulation. This simplification focuses on the most immunogenic and protective elements, reducing the complexity of vaccine development while maintaining or enhancing protective efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polypeptides effectively induce protective antibodies, enhancing the immune system's ability to recognize and eliminate Enterococci through opsonization, providing a promising solution for antibiotic-resistant strains.
Implementation Method 1
the polypeptide or contiguous fragment thereof induces opsonic antibodies in a patient in need thereof
Data Source
AI summary
Medicament for the treatment or the prevention of a bacterial infection, characterized in that it contains at least one polypeptide selected from the group of SEQ ID NO: 1 to SEQ ID NO: 9, and contiguous fragments thereof, wherein said at least one polypeptide or contiguous fragment thereof induces opsonic antibodies in a patient in need thereof. The polypeptides or the contiguous fragments thereof according to the present invention can be used for the preparation of a vaccine against an infection against Enterococcus.